News

Two recent papers by Dr. Jen Moliterno and her team help physicians better identify patients who may develop seizures alongside meningiomas.

The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of applied research and technology in the life sciences.

A team of Yale School of Medicine researchers is launching a study to determine the effect of vaccination on people with persistent symptoms months after SARS-CoV-2 infection, which has been termed “Long COVID.”

COVID-19: What We Know, What We Don’t Know & What is On The Horizon

In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING. STING has traditionally been implicated in the immune response to DNA damage, however, in this study, the focus is on STING’s role in the tumor DNA damage response.

Marina Picciotto, PhD, Charles B. G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, has been elected to the American College of Neuropsychopharmacology (ACNP) Council.

The Association of American Physicians and the American Society for Clinical Investigation have each elected three new members from the Yale School of Medicine faculty.

New Multidisciplinary Center for Lung Disease To Open in North Haven

Yale scientists have developed a new class of antiviral agents that shows promise for creating COVID-19 therapeutics — exhibiting particular effectiveness when used in tandem with the drug remdesivir, another antiviral medication approved for use against the virus.